4.5 Article

TRAIL shows potential cardioprotective activity

期刊

INVESTIGATIONAL NEW DRUGS
卷 30, 期 3, 页码 1257-1260

出版社

SPRINGER
DOI: 10.1007/s10637-010-9627-8

关键词

-

资金

  1. Programma di Ricerca Regione-Universita (Regione Emilia Romagna)
  2. Ministero dell'Universita e della Ricerca Scientifica e Tecnologica of Italy

向作者/读者索取更多资源

Recent clinical trials carried out in patients with advanced cancer have shown that recombinant TRAIL administration is usually safe and well tolerated when used either alone or in association with chemotherapeutic drugs. Notably, anticancer chemotherapy can be associated to cardiomiopathy. We have here demonstrated that TRAIL (administrated as either recombinant soluble TRAIL or as AAV-TRAIL expression viral vector) reduced the development of cardiomyopathy in the ApoE(-/-) diabetic mouse model. These data suggest, for the first time, that therapeutically administration of TRAIL might have a cardioprotective effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Bone morphogenetic protein 1.3 inhibition decreases scar formation and supports cardiomyocyte survival after myocardial infarction

Slobodan Vukicevic, Andrea Colliva, Vera Kufner, Valentina Martinelli, Silvia Moimas, Simone Vodret, Viktorija Rumenovic, Milan Milosevic, Boris Brkljacic, Diana Delic-Brkljacic, Ricardo Correa, Mauro Giacca, Manuel Maglione, Tatjana Bordukalo-Niksic, Ivo Dumic-Cule, Serena Zacchigna

Summary: This study demonstrates that the inhibition of the specific isoform of Bone Morphogenetic Protein 1 (BMP1.3) by a monoclonal antibody can reduce cardiac fibrosis and provide cardioprotection through inhibiting the Transforming Growth Factor beta pathway and inducing BMP5. It suggests the therapeutic potential of anti-BMP1.3 antibodies in preventing cardiomyocyte apoptosis, reducing collagen deposition, and preserving cardiac function after ischemia.

NATURE COMMUNICATIONS (2022)

Article Environmental Sciences

A new laser device for ultra-rapid and sustainable aerosol sterilization

Roman Vuerich, Valentina Martinelli, Simone Vodret, Iris Bertani, Tea Carletti, Lorena Zentilin, Vittorio Venturi, Alessandro Marcello, Serena Zacchigna

Summary: The current COVID-19 pandemic has emphasized the significance of aerosol-based transmission of human pathogens. To combat this, researchers have developed a new medical device that utilizes a 10600 nm laser light source to sterilize contaminated aerosols. This device has proven to be effective in killing aerosol-transmitted pathogens such as Legionella pneumophila and SARS-CoV-2.

ENVIRONMENT INTERNATIONAL (2022)

Editorial Material Biochemistry & Molecular Biology

Novel Targets for Old and Diseased Hearts

Erica Rurali, Giulio Pompilio, Serena Zacchigna

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

Biologics and cardiac disease: challenges and opportunities

Giulio Ciucci, Andrea Colliva, Roman Vuerich, Giulio Pompilio, Serena Zacchigna

Summary: This article reviews the latest research on the use of biologics in treating cardiac diseases and discusses the challenges they face in this field. By addressing these challenges, the development and approval of a new generation of biologics for cardiovascular diseases can be accelerated.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Cell Biology

Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library

Giulia Ruozi, Francesca Bortolotti, Antonio Mura, Mateusz Tomczyk, Antonella Falcione, Valentina Martinelli, Simone Vodret, Luca Braga, Matteo Dal Ferro, Antonio Cannata, Lorena Zentilin, Gianfranco Sinagra, Serena Zacchigna, Mauro Giacca

Summary: Through the cardiac FunSel method, researchers have identified three proteins (Chrdl1, Fam3c, and Fam3b) that can protect cardiomyocytes from pathological remodeling and myocardial infarction. Among them, Chrdl1 exerts its protective effect by inhibiting the activity of BMP4 and TGF-beta. These findings provide new insights into the search for cardiac protective factors and potential cardiac therapies.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Editorial Material Pharmacology & Pharmacy

Advancing cardiovascular translational research

Rebecca Ritchie, Suowen Xu, Serena Zacchigna

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Oncology

Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19

Rossana Bussani, Lorena Zentilin, Ricardo Correa, Andrea Colliva, Furio Silvestri, Serena Zacchigna, Chiara Collesi, Mauro Giacca

Summary: This study found that recovered COVID-19 patients may still experience worsening of their condition and eventually die, despite negative test results. Post-mortem analysis showed that the lung pathology of these patients was similar to that of acute COVID-19 cases, despite negative viral tests. These findings suggest that SARS-CoV-2 infection can persist longer than suggested by standard tests, with specific cell types in the lung being infected.

JOURNAL OF PATHOLOGY (2023)

Article Cardiac & Cardiovascular Systems

SARS-CoV-2 Spike protein activates TMEM16F-mediated platelet procoagulant activity

Ambra Cappelletto, Harriet E. Allan, Marilena Crescente, Edoardo Schneider, Rossana Bussani, Hashim Ali, Ilaria Secco, Simone Vodret, Roberto Simeone, Luca Mascaretti, Serena Zacchigna, Timothy D. Warner, Mauro Giacca

Summary: Thrombosis of the lung microvasculature is a key characteristic of severe COVID-19 infection, and is triggered by the Spike protein of SARS-CoV-2. The Spike protein enhances platelet activation and procoagulant activity, leading to clot formation. Niclosamide and Clofazimine effectively inhibit this Spike-induced procoagulant response and may be repurposed for COVID-19 therapy.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)

Article Biochemistry & Molecular Biology

Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression

Barbara Toffoli, Federica Tonon, Fabiola Giudici, Tommaso Ferretti, Elena Ghirigato, Matilde Contessa, Morena Francica, Riccardo Candido, Massimo Puato, Andrea Grillo, Bruno Fabris, Stella Bernardi

Summary: Night shift work is associated with an increased risk of cardiovascular and cerebrovascular disease, possibly due to the promotion of hypertension. This study conducted an analysis comparing blood pressure and clock gene expression in internists working day and night shifts. The results showed that night shift work significantly increased night blood pressure and heart rate and disrupted circadian rhythm. The findings suggest that night shifts contribute to higher blood pressure and circadian rhythm misalignment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence

Ubaldo Gioia, Sara Tavella, Pamela Martinez-Orellana, Giada Cicio, Andrea Colliva, Marta Ceccon, Matteo Cabrini, Ana C. Henriques, Valeria Fumagalli, Alessia Paldino, Ettore Presot, Sreejith Rajasekharan, Nicola Iacomino, Federica Pisati, Valentina Matti, Sara Sepe, Matilde I. Conte, Sara Barozzi, Zeno Lavagnino, Tea Carletti, Maria Concetta Volpe, Paola Cavalcante, Matteo Iannacone, Chiara Rampazzo, Rossana Bussani, Claudio Tripodo, Serena Zacchigna, Alessandro Marcello, Fabrizio d'Adda di Fagagna

Summary: SARS-CoV-2 causes DNA damage and alters the DNA damage response, leading to inflammation and cellular senescence.

NATURE CELL BIOLOGY (2023)

Article Endocrinology & Metabolism

Immunocytochemistry Profile of Benign Thyroid Nodules Not Responding to Thermal Ablation: A Retrospective Study

Stella Bernardi, Silvia Taccogna, Martina D'Angelo, Fabiola Giudici, Giovanni Mauri, Bruno Raggiunti, Doris Tina, Fabrizio Zanconati, Enrico Papini, Roberto Negro

Summary: The purpose of this study was to evaluate the immunocytochemistry profile of thyroid nodules with poor response to thermal ablation (TA) in order to identify potential predictors of treatment response. The absence of CK-19 was associated with resistance to TA, while the presence of CK-19 was predictive of response to TA. Therefore, the expression of CK-19 could provide rapid and low-cost information about the potential outcome of TA on thyroid nodules.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2023)

Letter Endocrinology & Metabolism

A case of cerebral salt wasting syndrome in a patient with central diabetes insipidus and status epilepticus

S. Bernardi, F. Zorat, V. Calabro, M. Faustini Fustini, B. Fabris

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2023)

Article Cell & Tissue Engineering

Ischemic wound revascularization by the stromal vascular fraction relies on host-donor hybrid vessels

Roman Vuerich, Elena Groppa, Simone Vodret, Nadja Annelies Ruth Ring, Chiara Stocco, Fleur Bossi, Chiara Agostinis, Matteo Cauteruccio, Andrea Colliva, Mohammad Ramadan, Francesca Simoncello, Federica Benvenuti, Anna Agnelli, Franca Dore, Flavia Mazzarol, Massimo Moretti, Alice Paulitti, Silvia Palmisano, Nicolo De Manzini, Mattia Chiesa, Manuel Casaburo, Angela Raucci, Daniela Lorizio, Giulio Pompilio, Roberta Bulla, Giovanni Papa, Serena Zacchigna

Summary: Nonhealing wounds have a negative impact on the quality of life for patients and health systems. Skin substitutes have been used, but have limited efficacy due to inadequate vascularization. The use of the stromal vascular fraction (SVF) from adipose tissue shows promise in overcoming this limitation, but additional research is needed to determine its precise mechanism of action.

NPJ REGENERATIVE MEDICINE (2023)

Article Medicine, General & Internal

Real-World Retrospective Study into the Effects of Oral Semaglutide (As a Switchover or Add-On Therapy) in Type 2 Diabetes

Riccardo Candido, Sara Gaiotti, Fabiola Giudici, Barbara Toffoli, Federica De Luca, Valerio Velardi, Alessandra Petrucco, Chiara Gottardi, Elena Manca, Iris Buda, Bruno Fabris, Stella Bernardi

Summary: This study demonstrates the effectiveness and safety of oral semaglutide as a switch or add-on therapy for patients with type 2 diabetes mellitus in a real-world setting, showing significant reductions in HbA1c and BMI.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes

Marzia De Bortoli, Viviana Meraviglia, Katarina Mackova, Laura S. Frommelt, Eva Konig, Johannes Rainer, Chiara Volani, Patrizia Benzoni, Maja Schlittler, Giada Cattelan, Benedetta M. Motta, Claudia Volpato, Werner Rauhe, Andrea Barbuti, Serena Zacchigna, Peter P. Pramstaller, Alessandra Rossini

Summary: This study used human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) to establish a model for incomplete penetrance in arrhythmogenic cardiomyopathy (ACM). The results showed molecular and functional differences between ACM and asymptomatic carriers of the same mutation (ASY) hiPSC-CMs, including a higher amount of mutated PKP2 mRNA, a lower expression of the connexin-43 protein, a lower overall density of sodium current, a higher intracellular lipid accumulation, and sarcomere disorganization in ACM compared to ASY hiPSC-CMs. Differentially expressed genes were also found, supporting a predisposition for a fatty phenotype in ACM hiPSC-CMs. This indicates that hiPSC-CMs are a suitable model to study incomplete penetrance in ACM.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2023)

暂无数据